Bello-Rivero, Iraldo <br/><br/>
HeberFERON, a new formulation of IFNs with improved pharmacodynamics: Perspective for cancer treatment.  [electronic resource] 

 -  Seminars in oncology  01 2018 
 - 27-33 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>1532-8708 
<br/><br/><label>Standard No.: </label>10.1053/j.seminoncol.2018.04.007  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Gene Expression Regulation, Neoplastic<br/>Humans<br/>Interferon alpha-2<br/>Interferon-alpha--administration & dosage<br/>Interferon-gamma--administration & dosage<br/>Neoplasms--drug therapy<br/>Proteome--metabolism<br/>Quality of Life<br/>Survival Analysis<br/>Treatment Outcome